ACP
LLY icon

Arcus Capital Partners’s Eli Lilly LLY Stock Holding History

Arcus Capital Partners’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-827
Closed -$482K – 117
2023
Q4 		$482K Buy
+827
New +$483K 0.17% 67
2016
Q1 		– Sell
-400
Closed -$34K – 77
2015
Q4 		$34K Buy
+400
New +$33.2K 0.02% 80

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Arcus Capital Partners's LLY Position: Q1 2024 in Review

Arcus Capital Partners sold out of Eli Lilly (LLY) in Q1 2024, closing a stake of 827 shares — an estimated $482K sold.

Arcus Capital Partners first reported a position in LLY in Q4 2015 and held it in 2 quarters. The position peaked at $482K in Q4 2023. 3,460 funds tracked by Wall St. Rank hold LLY as of Q1 2024.

  • Arcus Capital Partners reported no remaining Eli Lilly position as of Q1 2024 after selling out during the quarter.
  • Arcus Capital Partners sold 827 Eli Lilly shares in Q1 2024, an estimated $482K.
  • Arcus Capital Partners first reported a position in Eli Lilly in Q4 2015 and held it in 2 quarters.
  • Arcus Capital Partners's Eli Lilly position peaked at $482K in Q4 2023.
  • 3,460 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2024.

Based on Arcus Capital Partners's 13F filing for Q1 2024, filed 19 Apr 2024.